These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit. Calebiro D; Hannawacker A; Lyga S; Bathon K; Zabel U; Ronchi C; Beuschlein F; Reincke M; Lorenz K; Allolio B; Kisker C; Fassnacht M; Lohse MJ Nat Commun; 2014 Dec; 5():5680. PubMed ID: 25477193 [TBL] [Abstract][Full Text] [Related]
6. Inhibitors and fluorescent probes for protein kinase PKAcβ and its S54L mutant, identified in a patient with cortisol producing adenoma. Nonga OE; Enkvist E; Herberg FW; Uri A Biosci Biotechnol Biochem; 2020 Sep; 84(9):1839-1845. PubMed ID: 32507034 [TBL] [Abstract][Full Text] [Related]
7. Clinical and Molecular Characteristics of PRKACA L206R Mutant Cortisol-Producing Adenomas in Korean Patients. Jang I; Kim SJ; Song RY; Kim K; Choi S; Lee JS; Gwon MK; Seong MW; Lee KE; Kim JH Endocrinol Metab (Seoul); 2021 Dec; 36(6):1287-1297. PubMed ID: 34852451 [TBL] [Abstract][Full Text] [Related]
8. Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations. Baba R; Oki K; Gomez-Sanchez CE; Otagaki Y; Itcho K; Kobuke K; Kodama T; Nagano G; Ohno H; Yoneda M; Hattori N Mol Cell Endocrinol; 2021 Dec; 538():111456. PubMed ID: 34520814 [TBL] [Abstract][Full Text] [Related]
9. PRKACB variants in skeletal disease or adrenocortical hyperplasia: effects on protein kinase A. Espiard S; Drougat L; Settas N; Haydar S; Bathon K; London E; Levy I; Faucz FR; Calebiro D; Bertherat J; Li D; Levine MA; Stratakis CA Endocr Relat Cancer; 2020 Nov; 27(11):647-656. PubMed ID: 33055300 [TBL] [Abstract][Full Text] [Related]
10. Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome. Bathon K; Weigand I; Vanselow JT; Ronchi CL; Sbiera S; Schlosser A; Fassnacht M; Calebiro D Endocrinology; 2019 Feb; 160(2):447-459. PubMed ID: 30615103 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase A defects and cortisol-producing adrenal tumors. Zilbermint M; Stratakis CA Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):157-62. PubMed ID: 25871963 [TBL] [Abstract][Full Text] [Related]
12. Is Disrupted Nucleotide-Substrate Cooperativity a Common Trait for Cushing's Syndrome Driving Mutations of Protein Kinase A? Walker C; Wang Y; Olivieri C; V S M; Gao J; Bernlohr DA; Calebiro D; Taylor SS; Veglia G J Mol Biol; 2021 Sep; 433(18):167123. PubMed ID: 34224748 [TBL] [Abstract][Full Text] [Related]
13. Cushing's syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity. Walker C; Wang Y; Olivieri C; Karamafrooz A; Casby J; Bathon K; Calebiro D; Gao J; Bernlohr DA; Taylor SS; Veglia G Sci Adv; 2019 Aug; 5(8):eaaw9298. PubMed ID: 31489371 [TBL] [Abstract][Full Text] [Related]
14. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome. Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472 [TBL] [Abstract][Full Text] [Related]